Gola Corporate Real Estate recently represented iECURE in the leasing of their headquarters space at 1777 Sentry Parkway West in Blue Bell, PA.  iECURE is a leading gene editing company focused on developing therapies that utilize mutation-agnostic in vivi gene insertion, or knock-in editing for the treatment of liver disorders with significant unmet need that recently raised $65 million to advance in vivo gene editing program.

iECURE’s COO Paul Firuta shared his experience with Gola:

As an early stage biotech, we needed to find an office location appropriate for the company’s Phase of development. The Gola Team was excellent at listening to our business needs and understanding important aspects of finding office space – for example, size, location, duration, furnishings, ability to recruit top talent and flexibility. 

Initially, we sourced spec space for a 1 year term.  Nine months into the lease, we identified the need to expand the company and secure much larger space to recruit outstanding talent and provide a great work environment that reflects iECURE culture.  The Gola team helped us secure the lease and negotiate favorable terms and ensuring we had the appropriate office location to continue to expand the company as the company moves into later stages of clinical  development.

Read more about iECURE’s latest funding round in the Philadelphia Business Journal:
iEcure raises $65M to advance its gene-..

For more information, please contact Mark Gola.